This is of vital importance in type 1 and advanced type 2 diabetes where the regimen constitutes full insulin-replacement therapy but, in earlier stages of type 2 diabetes, simpler, more convenient regimens may suffice and aid adherence. The gene discussed is INS; the disease is type 2 diabetes mellitus.